Advertisement
OtherReview Article

Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes

Roman Tremmel, Daniel Hübschmann, Elke Schaeffeler, Sebastian Pirmann, Stefan Fröhling and Matthias Schwab
Pharmacological Reviews October 15, 2024, PHARMREV-AR-2023-001049; DOI: https://doi.org/10.1124/pharmrev.124.001049
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherReview Article

Pharmacogenomics in cancer pharmacotherapy

Roman Tremmel, Daniel Hübschmann, Elke Schaeffeler, Sebastian Pirmann, Stefan Fröhling and Matthias Schwab
Pharmacological Reviews October 15, 2024, PHARMREV-AR-2023-001049; DOI: https://doi.org/10.1124/pharmrev.124.001049
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement